Loading clinical trials...
Loading clinical trials...
Efficacy and Safety of 12 Months of Therapy With Inhaled Colistimethate Sodium in Subjects With Non-cystic Fibrosis Bronchiectasis Chronically Infected With P. Aeruginosa
Conditions
Interventions
CMS
Placebo
Locations
89
United States
Zambon Investigative Site
Newport Beach, California, United States
Zambon Investigative Site
Palm Springs, California, United States
Zambon Investigative Site
Reseda, California, United States
Zambon investigative site
San Diego, California, United States
Zambon Investgative Site
San Diego, California, United States
Zambon Investigative Site
Centennial, Colorado, United States
Start Date
January 29, 2018
Primary Completion Date
March 15, 2022
Completion Date
March 15, 2022
Last Updated
December 29, 2023
Lead Sponsor
Zambon SpA
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions